| Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working … CG Tocchetti, P Ameri, RA de Boer, Y D’Alessandra, M Russo, ... Cardiovascular Research 116 (11), 1820-1834, 2020 | 61 | 2020 |
| A comorbidity model of myocardial ischemia/reperfusion injury and hypercholesterolemia in rat cardiac myocyte cultures A Makkos, Á Szántai, J Pálóczi, J Pipis, B Kiss, P Poggi, P Ferdinandy, ... Frontiers in physiology 10, 1564, 2020 | 23 | 2020 |
| Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion GB Brenner, A Makkos, CT Nagy, Z Onódi, NV Sayour, TG Gergely, B Kiss, ... Cells 9 (3), 551, 2020 | 19 | 2020 |
| Decorin Protects Cardiac Myocytes against Simulated Ischemia/Reperfusion Injury R Gáspár, K Gömöri, B Kiss, Á Szántai, J Pálóczi, ZV Varga, J Pipis, ... Molecules 25 (15), 3426, 2020 | 14 | 2020 |
| L-Alpha-glycerylphosphorylcholine can be cytoprotective or cytotoxic in neonatal rat cardiac myocytes: A double-edged sword phenomenon E Tuboly, R Gáspár, MO Ibor, K Gömöri, B Kiss, G Strifler, P Hartmann, ... Molecular and cellular biochemistry 460 (1), 195-203, 2019 | 14 | 2019 |
| Cardiac miRNA Expression and their mRNA Targets in a Rat Model of Prediabetes É Sághy, I Vörös, B Ágg, B Kiss, G Koncsos, ZV Varga, A Görbe, Z Giricz, ... International journal of molecular sciences 21 (6), 2128, 2020 | 13 | 2020 |
| Systematic analysis of different pluripotent stem cell-derived cardiac myocytes as potential testing model for cardiocytoprotection J Pálóczi, Á Szántai, J Kobolák, I Bock, E Ruivo, B Kiss, R Gáspár, J Pipis, ... Vascular Pharmacology 133, 106781, 2020 | 3 | 2020 |
Görbe AnikóSemmelweis University, University of SzegedVerified email at med.u-szeged.hu
